BEYOND IMMORTALITY: European Wellness Biomedical Group Unveils Landmark Research on Longevity Through Cell Regeneration Over Organ Transplants

Core Insights - The European Wellness Biomedical Group (EWBG) emphasizes that true longevity is achieved through cellular regeneration rather than organ transplantation, focusing on healthspan over lifespan [1][3][17] - Prof. Mike Chan's recent publications include the Human Cytology Atlas, which maps over 400 distinct human cell types, and a study on organ aging, highlighting the varying rates at which different organs age [1][11][24] Company Developments - EWBG has published significant scientific contributions, including the Human Cytology Atlas and a peer-reviewed study on organ aging, reinforcing its position in the field of regenerative medicine [1][10][24] - The company is involved in global collaborations, such as working with the Chinese government on autism therapies and ongoing research with Heidelberg University in Germany and Switzerland [14][24][25] Industry Trends - The conversation around longevity is shifting from organ transplantation to cellular regeneration, with a focus on targeted therapies that address the cellular mechanisms of aging [6][12][17] - Prof. Chan advocates for precision medicine that tailors interventions to individual cellular profiles, aiming to extend healthspan rather than merely increasing lifespan [13][21]